Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 10/20 | 0.52 |
| ▸ | CCR1 | P32246 | 1/20 | 0.48 |
| ▸ | CCR5 | P51681 | 1/20 | 0.48 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.48 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.43 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.43 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.43 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.43 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.43 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28510248 | 1.00 | CCR2 (0.52) | CCR2CCR1CCR5CXCR4PSEN1 | |
| SCHEMBL5871975 | 1.00 | CCR2 (0.52) | CCR2CCR1CCR5CXCR4PSEN1 | |
| SCHEMBL229898 | 1.00 | CCR2 (0.52) | CCR2CCR1CCR5CXCR4PSEN1 | |
| SCHEMBL15253305 | 1.00 | CCR2 (0.52) | CCR2CCR1CCR5CXCR4PSEN1 | |
| SCHEMBL9003899 | 1.00 | CCR2 (0.52) | CCR2CCR1CCR5CXCR4PSEN1 | |
| SCHEMBL181231 | 0.98 | CCR2 (0.51) | CCR2CCR1CCR5CXCR4PSEN1 | |
| SCHEMBL9978692 | 0.95 | CCR2 (0.47) | CCR2CCR1CCR5CXCR4PSEN1 | |
| SCHEMBL7622441 | 0.95 | CCR2 (0.47) | CCR2CCR1CCR5CXCR4PSEN1 | |
| SCHEMBL1401505 | 0.93 | CCR2 (0.46) | CCR2CCR1CCR5CXCR4PSEN1 | |
| SCHEMBL1706310 | 0.93 | CCR2 (0.48) | CCR2CCR1CCR5CXCR4PSEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240390279-A1 | MICELLAR SOLUTION COMPRISING DICLOFENAC | HALEON CH SARL (CH) | 2024-11-28 | — | — | US | claimed |
| EP-4362910-A1 | MICELLAR SOLUTION COMPRISING DICLOFENAC | Haleon CH SARL (CH) | 2024-05-08 | — | — | EP | claimed |
| CN-116209428-A | Treatment of emesis and nausea with minimal doses of olanzapine | 斯塔顿治疗公司 | 2023-06-02 | — | — | CN | claimed |
| WO-2023275003-A1 | MICELLAR SOLUTION COMPRISING DICLOFENAC | GSK CONSUMER HEALTHCARE SARL (CH) | 2023-01-05 | — | — | WO | claimed |
| EP-4112041-A1 | MICELLAR SOLUTION COMPRISING DICLOFENAC | GSK Consumer Healthcare SARL (CH) | 2023-01-04 | — | — | EP | claimed |
| CN-114901287-A | Treatment of emesis and nausea with minimal dose of olanzapine | 斯塔顿治疗公司 | 2022-08-12 | — | — | CN | claimed |
| EP-2531229-B1 | MEDICINE PRODUCT WITH A PARTICLE-FREE COATING RELEASING AN ACTIVE SUBSTANCE | HEMOTEQ AG (DE) | 2014-12-31 | — | — | EP | claimed |
| CN-102905735-B | Medical product with particle-free coating releasing active substance | HEMOTEQ AG | 2014-12-03 | — | — | CN | claimed |
| US-20130245058-A1 | MEDICAL PRODUCT WITH A PARTICLE-FREE COATING RELEASING AN ACTIVE SUBSTANCE | HEMOTEQ AG (DE) | 2013-09-19 | — | — | US | claimed |
| CN-102905735-A | Medical product with particle-free coating releasing active substance | HEMOTEQ AG | 2013-01-30 | — | — | CN | claimed |
| WO-2011147408-A2 | MEDICAL PRODUCT WITH A PARTICLE-FREE COATING RELEASING AN ACTIVE SUBSTANCE | HEMOTEQ AG (DE) | 2011-12-01 | — | — | WO | claimed |
| EP-1024691-A4 | SOLUBLE POLYMER BASED MATRIX FOR CHEMICALLY ACTIVE WATER INSOLUBLE COMPONENTS | ISP INVESTMENTS INC (US) | 2004-08-18 | — | — | EP | claimed |
| CN-1084146-C | Emulsifiable composition for disinsectization | RHONE POULENC AGROCHIMIE (FR) | 2002-05-08 | — | — | CN | claimed |
| EP-1024691-A1 | SOLUBLE POLYMER BASED MATRIX FOR CHEMICALLY ACTIVE WATER INSOLUBLE COMPONENTS | ISP INVESTMENTS INC. (US) | 2000-08-09 | — | — | EP | claimed |
| WO-1998033378-A1 | SOLUBLE POLYMER BASED MATRIX FOR CHEMICALLY ACTIVE WATER INSOLUBLE COMPONENTS | ISP INVESTMENTS INC. (US) | 1998-08-06 | — | — | WO | claimed |
| US-5776856-A | Soluble polymer based matrix for chemically active water insoluble components | ISP INVESTMENTS INC. (US) | 1998-07-07 | — | — | US | claimed |
| CN-1166773-A | Emulsifiable composition for disinsectization | RHONE POULENC AGROCHIMIE (FR) | 1997-12-03 | — | — | CN | claimed |
| EP-0794702-A2 | EMULSIFIABLE COMPOSITION FOR THE CONTROL OF INSECTS | RHONE-POULENC AGROCHIMIE (FR) | 1997-09-17 | — | — | EP | claimed |
| WO-1996016544-A2 | EMULSIFIABLE COMPOSITION FOR THE CONTROL OF INSECTS | RHONE-POULENC AGROCHIMIE (FR) | 1996-06-06 | — | — | WO | claimed |
| EP-0552879-A1 | Improved iontophoretic administration of drugs | MACROCHEM CORPORATION (US) | 1993-07-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130245058-A1 | MEDICAL PRODUCT WITH A PARTICLE-FREE COATING RELEASING AN ACTIVE SUBSTANCE | CD44, VEGFA, CD63 | CCR2 1208/4885CCR1 581/4885CCR5 1349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.